Tech Center 1600 • Art Units: 1600 1644 1674
This examiner grants 60% of resolved cases
Zachary S. Skelding has managed 834 resolved cases in Tech Center 1600. The examiner's allowance rate stands at 59.7 percent. This rate reflects the outcomes across a substantial volume of applications, providing a robust statistical foundation for prosecution planning in Art Unit 1600. Practitioners should note that this 59.7 percent allowance rate is a primary benchmark for success.
Direct engagement appears to be a productive tactic, as evidenced by an interview lift of 41.2 percent. This figure indicates that cases are significantly more likely to reach an allowance following a formal interview compared to the baseline. Practitioners should consider this 41.2 percent lift when deciding whether to request a meeting to discuss claim amendments or clarify technical points.
The median days to allowance for successful applications is 1331, indicating the typical timeline for reaching a favorable resolution. This duration of 1331 days helps in managing client expectations regarding the speed of the patent acquisition process in Tech Center 1600. By combining the volume of 834 resolved cases with the pendency data, practitioners can develop a comprehensive strategy for this art unit.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18046865 | METHODS FOR ASSAYING T-CELL DEPENDENT BISPECIFIC ANTIBODIES | Final Rejection | Genentech, Inc. |
| 18477532 | CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING THE TUMOR MICROENVIRONMENT | Non-Final OA | The General Hospital Corporation |
| 18142129 | GLYCOENGINEERING | Non-Final OA | The General Hospital Corporation |
| 18184860 | BCMA CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | Non-Final OA | Novartis AG |
| 18045946 | LIQUID FORMULATION OF HUMANIZED ANTIBODY FOR TREATING IL-6-MEDIATED DISEASES | Non-Final OA | Bio-Thera Solutions, Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy